Schizoaffective disorder merges schizophrenia and bipolar disorders as one disease - There is no schizoaffective disorder

Current Opinion in Psychiatry

Volumn 20, Issue 4, 2007, Pages 365-379

  Lake, Charles Ray ^a   Hurwitz, Nathaniel ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b VA Medical Center   (United States)

Author keywords

Bipolar disorder; Kraepelinian dichotomy; Mania; Psychosis; Schizoaffective disorder; Schizophrenia

Indexed keywords

BIPOLAR DISORDER; COGNITIVE DEFECT; COMPARATIVE STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; DISEASE COURSE; EPIDEMIOLOGICAL DATA; GENE LOCUS; GENETIC LINKAGE; HERITABILITY; HUMAN; INTERRATER RELIABILITY; MOLECULAR GENETICS; MOOD DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL THEORY; PSYCHOSIS; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUICIDE; SYMPTOMATOLOGY; VALIDITY;

BIPOLAR DISORDER; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); PSYCHOLOGICAL THEORY; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 34250003212     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3281a305ab     Document Type: Review

References (150)

1. Kasanin J. The acute schizoaffective psychoses. Am J Psychiatry 1933; 13:97-126.
2. Bleuler E. Dementia praecox or the group of schizophrenias. New York: International Universities Press; 1911/1950.
3. Kraepelin E. Clinical psychiatry. New York: William Wood; 1913.
4. Cobb S. Borderlands of psychiatry. Cambridge: Harvard University Press; 1943.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed-TR. Washington: American Psychiatric Press; 2000.
6. Lake CR, Hurwitz N. Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders. Psychiatry Res 2006; 143:255-287. A comprehensive review of SAD; quoted in Table 2.
7. Procci WR. Schizo-affective psychosis: fact or fiction. Arch Gen Psychiatry 1976; 33:1167-1178.
8. Pope HG, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness, a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch Gen Psychiatry 1978; 35:811-828.
9. Brockington IF, Leff JP. Schizoaffective psychosis: definition and incidence. Psychol Med 1979; 9:91-99.
10. Brockington IF, Kendell RE, Wainwright S, et al. The distinction between the affective psychoses and schizophrenia. Br J Psychiatry 1979; 135:243-248.
11. Pope HG, Lipinski JF, Cowen BM, Axelrod DT. Schizoaffective disorder: an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980; 137:921-927.
12. Schwartz JE, Fennig S, Tanenberg-Karant M, et al. Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Arch Gen Psychiatry 2000; 57:593-600.
13. Swartz CM. Schizoaffective defective. Psychiatric Times Nov, 2002; 29-32.
14. Averill PM, Reas DL, Shack A, et al. Is schizoaffective disorder a stable diagnostic category: a retrospective examination. Psychiatr Q 2004; 75:215-227.
15. Maier W. Do schizoaffective disorders exist at all? Acta Psychiatr Scand 2006; 13:369-371. One of the most recent editorials addressing the rationale for dropping the concept of SAD; quoted in Table 2.
16. Vollmer-Larsen A, Jacobsen TB, Hemmingsen R, Parnas J. Schizoaffective disorder - the reliability of its clinical diagnostic use. Acta Psychiatr Scand 2006; 113:402-407. A recent paper showing the absence of reliability of SAD; quoted in Table 2.
17. Harrow M, Grossman LS, Herbener ES, Davies EW. Ten-year outcome: patients with schizoaffective disorders, schizophrenia, affective disorders and mood-incongruent psychotic symptoms. Br J Psychiatry 2000; 177:421-426.
18. Kendell RE, Gourlay J. The clinical distinction between the affective psychoses and schizophrenia. Br J Psychiatry 1970; 117:261-266.
19. Gonzalez-Pinto A, van Os J, Perez de Heredia JL, et al. Age-dependence of Schneiderian psychotic symptoms in bipolar patients. Schizophr Res 2003; 61:157-162.
20. Fink M, Taylor MA. Catatonia: subtype or syndrome in DSM? Am J Psychiatry 2006; 163:1875-1876. A paper showing the syndrome of catatonia is more frequently associated with patients diagnosed with bipolar and not schizophrenia casting doubt on one of the major subtypes and diagnostic criteria of schizophrenia; quoted in Table 2.
21. Swartz CM. Schizophrenic schizophrenia. Psychiatric Times Oct 2002; 47-51.
22. Dieperink ME, Sands JR. Bipolar mania with psychotic features: diagnosis and treatment. Psychiatr Ann 1996; 26:633-637.
23. McIntosh AM, Harrison LK, Forrester K, et al. Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. Br J Psychiatry 2005; 186:378-385.
24. Tiihonen J, Haukka J, Henriksson M, et al. Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts. Am J Psychiatry 2005; 162:1904-1910.
25. Pini S, Cassano GB, Dell 'Osso L, Amador XF. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry 2001; 158:122-125.
26. Maj M, Pirozzi R, Formicola AM, et al. Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data. J Affect Disord 2000; 57:95-98.
27. Crow TJ. The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 1986; 149:419-429.
28. Azorin JM, Kaladjian A, Fakra E. Current issues on schizoaffective disorder. Encephale 2005; 31:359-365.
29. Laursen TM, Labouriau R, Licht RW, et al. Family history of psychiatric illness as a risk factor for schizoaffective disorder. Arch Gen Psychiatry 2005; 62:841-848.
30. Korn ML. Schizophrenia and Bipolar disorder: an evolving interface. Medscape Psychiatry Ment Health 2004; 9:1-5.
31. Ketter T, Wang PW, Becker OV, et al. Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? J Psychiatr Res 2004; 38:47-61.
32. Moller HJ. Bipolar disorder and schizophrenia: distinct illnesses or a continuum? J Clin Psychiatry 2003; 64:23-27.
33. Jager M, Bottlender R, Strauss A, Moller HJ. Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders. Acta Psychiatr Scand 2004; 109:30-37.
34. Nardi AE, Nascimento I, Freire RC, et al. Demographic and clinical features of schizoaffective (schizobipolar) disorder - a 5-year retrospective study. Support for bipolar spectrum disorder. J Affect Disord 2005; 89:201-206.
35. Baethge C, Gruschka P, Berghofer A, et al. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up. J Affect Disord 2004; 79:43-50.
36. Benabarre A, Vieta E, Colom F, et al. Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry 2001; 16:167-172.
37. Valles V, Van Os J, Guillamat R, et al. Increased morbid risk for schizophrenia in families of in-patients with bipolar illness. Schizophr Res 2000; 42:83-90.
38. Berrettini WH. Are schizophrenic and bipolar disorders related? A review of family and molecular studies. Biol Psychiatry 2000; 48:531-558.
39. Berrettini WH. Molecular linkage studies of bipolar disorders. Bipolar Disord 2001; 3:276-283.
40. Berrettini W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am J Med Genet 2003; 123:59-64.
41. Cardno AG, Rysdijk FV, Sham PC, et al. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 2002; 159:539-545.
42. Craddock N, Owen MJ. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry 2005; 184:384-386.
43. Craddock N, O'Donovan MC, Owen M. The genetics of schizophrenia and bipolar disorder dissecting psychosis. J Med Genet 2005; 42:193-204.
44. Hamshere ML, Bennett P, Williams N, et al. Genomewide linkage scan in schizoaffective disorder. Arch Gen Psychiatry 2005; 62:1081-1088.
45. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D- aspartate receptor subunit NR2A in the anterior cingulated cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2004; 61:649-657.
46. Kohn Y, Lerer B. Excitement and confusion on chromosome 6q: the challenges of neuropsychiatric genetics in microcosm. Mol Psychiatry 2005; 10:1062-1073.
47. Crow TJ. How and why genetic linkage has not solved the problem of psychosis: review and hypothesis. Am J Psychiatry 2007; 164:13-22. The latest in the development of the continuum theory supporting a single disorder; quoted in Table 2.
48. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003; 160:4-12.
49. Williams NM, Green EK, Macgregor S, et al. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2006; 63:366-373. A recent update on variation at DAOA/G30 associating with mood disorders; quoted in Table 2.
50. Hodgkinson CA, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder and bipolar disorder. Am J Hum Genet 2004; 75:862-872.
51. Mansour HA, Wood J, Logue T, et al. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behavior 2006; 5:150-157. Examines relationships between genes that mediate circadian function and bipolar, SAD and schizophrenia; quoted in Table 2.
52. Schulze TG, Ohlraun S, Czerski P, et al. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: a first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 2005; 162:2101-2108.
53. Schurhoff F, Szoke A, Meary A, et al. Familial aggregation of delusional proneness in schizophrenia and bipolar pedigrees. Am J Psychiatry 2003; 160:1313-1319.
54. Murray RM, Sham P, Van Os J, et al. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 2004; 71:405-416.
55. Koh PO, Undie AS, Kabbani N, et al. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenia and bipolar patients. Proc Natl Acad Sci USA 2003; 100:313-317.
56. Tkachev D, Minnack ML, Ryan MM, et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003; 362:798-805.
57. Marx CE, Stevens RD, Shampine LJ, et al. Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics. Neuropsychopharmacology 2006; 31:1249-1263. Links neuroactive steroid neurotransmission dysfunction to schizophrenia and bipolar; quoted in Table 2.
58. McCullumsmith RE, Meador-Woodruff JH. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder. Neuropsychopharmacology 2002; 26:368-375.
59. Chambers JS, Perrone-Bizzozero NI. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res 2004; 29:2293-2302.
60. Maier W, Zobel A, Wagner M. Schizophrenia and bipolar disorder: differences and overlaps. Curr Opin Psychiatry 2006; 19:165-170. An outstanding review of the similarities between schizophrenia and bipolar with a clear conclusion; quoted in Table 2.
61. Hafner H, Maurer K, Trendier G, et al. Schizophrenia and depression: challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77:11-24.
62. Maziade M, Roy MA, Chagnon YC, et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatry 2005; 10:486-499.
63. 18F-labelled fluorodeoxyglucose and positron emission tomography. Br J Psychiatry 1996; 169:509-516.
64. Roy PD, Zipursky RB, Saint-Cyr JA, et al. Temporal horn enlargement is present in schizophrenia and bipolar disorder. Biol Psychiatry 1998; 44:418-422.
65. Olincy A, Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 2005; 162:43-49.
66. Politis A, Lykouras L, Mourtzouchou P, Christodoulou GN. Attentional disturbances in patients with unipolar psychotic depression: a selective and sustained attention study. Compr Psychiatry 2004; 45:452-459.
67. Fawcett J. What do we know for sure about bipolar disorder? Am J Psychiatry 2005; 162:1-2.
68. Schneider K. Clinical psychopathology. New York: Grune & Stratton; 1959.
69. Taylor MA, Gaztanaga P, Abrams R. Manic-depressive illness and acute schizophrenia: a clinical, family history and treatment-response study. Am J Psychiatry 1974; 131:678-682.
70. Kendler KS. Mood-incongruent psychotic affective illness: a historical and empirical review. Arch Gen Psychiatry 1991; 48:362-369.
71. Harrow M, Grossman LS, Silverstein ML, Meltzer HY. Thought pathology in manic and schizophrenic patients. Arch Gen Psychiatry 1982; 39:665-671.
72. Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992; 149:1580-1584.
73. Harrow M, MacDonald AW III, Sands JR, Silverstein ML. Vulnerability to delusions over time in schizophrenia and affective disorders. Schizophr Bull 1995; 21:95-109.
74. Ollerenshaw DP. The classification of the functional psychoses. Br J Psychiatry 1973; 122:517-530.
75. Abrams R, Taylor MA, Gaztanaga P. Manic-depressive illness and paranoid schizophrenia. Arch Gen Psychiatry 1974; 31:640-642.
76. Carpenter WT, Strauss JS, Muleh S. Are there pathognomonic symptoms in schizophrenia? An empiric investigation of Schneider's first-rank symptoms. Arch Gen Psychiatry 1973; 28:847-852.
77. Taylor MA, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973; 29:520-522.
78. Carlson GA, Goodwin FK. The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry 1973; 28:221-228.
79. Fowler RC, McCabe MS, Cadoret RJ, Winokur G. The validity of good prognosis schizophrenia. Arch Gen Psychiatry 1972; 26:182-185.
80. Guze SB, Woodruff RA, Clayton PJ. The significance of psychotic affective disorders. Arch Gen Psychiatry 1975; 32:1147-1150.
81. Grossman LS, Harrow M, Sands JR. Features associated with thought disorder in manic patients at 2-4-year follow-up. Am J Psychiatry 1986; 143:306-311.
82. Abrams R, Taylor MA. Catatonia, a prospective clinical study. Arch Gen Psychiatry 1976; 33:579-581.
83. Kruger S, Braunig P. Catatonia in affective disorders: new findings and a review of the literature. CNS Spectrums 2000; 5:48-53.
84. Carroll BT, Thomas C, Jayanti K, et al. Treating persistent catatonia when benzodiazepines fail. Curr Psychiatry 2005; 4:56-64.
85. Goodwin FK. The biology of recurrence: new directions for the pharmacologic bridge. J Clin Psychiatry 1989; 50:40-44.
86. Taylor MA, Amir N. Are schizophrenia and affective disorder related?: The problem of schizoaffective disorder and the discrimination of the psychoses by signs and symptoms. Compr Psychiatry 1994; 35:420-429.
87. Pope HG. Distinguishing bipolar disorder from schizophrenia in clinical practice; Guidelines and case reports. Hosp Community Psychiatry 1983; 34:322-328.
88. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149:999-1010.
89. Pierson A, Jouvent R, Quintin P, et al. Information processing deficits in relatives of manic depressive patients. Psychol Med 2000; 30:545-555.
90. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search of genes associated with bipolar affective disorder. Bipolar Disorder 2004; 6:171-182.
91. Goodwin FK, Jamison KR. Manic-depressive illness. New York: Oxford University Press; 1990.
92. Abrams R, Taylor MA. Importance of schizophrenic symptoms in the diagnosis of mania. Am J Psychiatry 1981; 138:658-661.
93. Taylor MA. Are schizophrenia and affective disorder related? A selective review. Am J Psychiatry 1992; 149:22-32.
94. Kraepelin E. Die Erscheinungsformen des Irreseins [The manifestations of insanity]. Z ges Neurol Psychiat 1920; 62:1-29.
95. Tsuang MT, Dempsey GM, Rauscher F. A study of 'atypical schizophrenia': a comparison with schizophrenia and affective disorder by sex, age of admission, precipitant, outcome and family history. Arch Gen Psychiatry 1976; 33:1157-1160.
96. Szasz TS. Schizophrenia: the sacred symbol of psychiatry. Br J Psychiatry 1976; 129:308-316.
97. Kendler KS, McGuire M, Gruenberg AM, Walsh D. Examining the validity of DSM-II-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study. Am J Psychiatry 1995; 152:755-764.
98. Evans JD, Heaton RI, Paulsen JS, et al. Schizoaffective disorder: a form of schizophrenia or affective disorder? J Clin Psychiatry 1999; 60:874-882.
99. Croughan JL, Welner A, Robins E. The group of schizoaffective and related psychoses - critique, record, follow-up and family studies. Arch Gen Psychiatry 1974; 31:632-637.
100. Himmelhoch JM, Fuchs CZ, May SJ, et al. When a schizoaffective diagnosis has meaning. J Nerv Ment Dis 1981; 169:277-282.
101. Shenton ME, Solovay MR, Holzman P. Comparative studies of thought disorders. II. Schizoaffective disorder. Arch Gen Psychiatry 1987; 44:21-30.
102. Tsuang MT. Morbidity risks of schizophrenia and affective disorders among first-degree relatives of patients with schizoaffective disorders. Br J Psychiatry 1991; 158:165-170.
103. Lapierre YD. Schizophrenia and manic-depression: separate illnesses or a continuum? Can J Psychiatry 1994; 39:S59-S64.
104. Maier W, Lichtermann D, Minges J, et al. Schizoaffective disorder and affective disorders with mood-incongruent psychotic features: keep separate or combine? Evidence from a family study. Am J Psychiatry 1992; 149:1666-1673.
105. Cloninger CR, Martin RL, Guze SB, Clayton PJ. Diagnosis and prognosis in schizophrenia. Arch Gen Psychiatry 1985; 42:15-25.
106. Tsuang MT. Schizoaffective disorder: dead or alive? Arch Gen Psychiatry 1979; 36:633-634.
107. Clayton PC. Schizoaffective disorders. J Nerv Ment Dis 1982; 170:646-650.
108. Levinson DF, Levitt MEM. Schizoaffective mania reconsidered. Am J Psychiatry 1987; 144:415-425.
109. Doran AR, Breier A, Roy A. Differential diagnosis and diagnostic systems in schizophrenia. Psychiatr Clin North Am 1986; 9:17-33.
110. Angst J, Felder W, Lohmeyer B. Schizoaffective disorders. Results of a genetic investigation: I. J Affect Disord 1979; 1:139-153.
111. Ricca V, Galassi F, La Malfa G, et al. Assessment of basic symptoms in schizophrenia, schizoaffective and bipolar disorders. Psychopathology 1997; 30:53-58.
112. Bhrolchain MN, Brown GW, Harris TO. Psychotic and neurotic depression: 2. Clinical characteristics. Br J Psychiatry 1979; 143:94-107.
113. Welner A, Croughan J, Fishman R, Robins E. The group of schizoaffective and related psychoses: a follow-up study. Compr Psychiatry 1977; 18:413-422.
114. Coryell W, Lavori P, Endicott J, et al. Outcome in schizoaffective, psychotic and nonpsychotic depression. Course during a six-to 24-month follow-up. Arch Gen Psychiatry 1984; 41:787-791.
115. Beck AT. Depression: causes and treatment. Philadelphia: University of Pennsylvania Press; 1967.
116. Crow TJ. The continuum of psychoses and its genetic origins. The sixty-fifth Maudsley lecture. Br J Psychiatry 1990; 156:788-797.
117. Crow TJ. Nature of the genetic contribution to psychotic illness: a continuum viewpoint. Acta Psychiatr Scand 1990; 81:401-408.
118. Yasamy MT. Schizoaffective disorder: a dimensional approach. Acta Psychiatr Scand 1987; 76:609-618.
119. Gershon ES, Hamovit J, Guroff JJ, et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar and normal control probands. Arch Gen Psychiatry 1982; 39:1157-1167.
120. Meltzer HY. Schizoaffective disorder: is the news of its nonexistence premature? Schizophr Bull 1984; 10:11-13.
121. Tsuang MT, Simpson JC. Schizoaffective disorder: concept and reality. Schizophr Bull 1984; 10:14-25.
122. Cardno AG, Marshall EJ, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatry 1999; 56:162-168.
123. McDonald C, Bullmore ET, Sham PC, et al. Association of genetic risks or schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry 2004; 61:974-984.
124. Weiser M, Van Os J, Davidson M. Time for a shift in focus in schizophrenia: from narrow phenotypes to broad endophenotypes. Br J Psychiatry 2005; 187:203-205.
125. Alsthuler LL, Bartzokis G, Grieder T, et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry 2000; 15:147-162.
126. McDonald C, Marshall N, Sham PC, et al. Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. Am J Psychiatry 2006; 163:478-487.
127. Rosack J. Dopamine pathway may link schizophrenia, bipolar disorder. Psychiatr News 2003; 38:21-22.
128. Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001; 55:651-659.
129. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar Disorder 2001; 3:106-150.
130. Tohen M, Chengappa KN, Suppes T, et al. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabilizer v. mood stabilizer alone. Br J Psychiatry 2004; 184:337-345.
131. Mason PS. Atypical antipsychotics in the treatment of affective symptoms: a review. Ann Clin Psychiatry 2004; 16:3-13.
132. Casey DE, Daniel DG, Wassef AA, et al. Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 2003; 28:182-192.
133. Yatham LN. Efficacy of atypical antipsychotics in mood disorders. J Clin Psychopharmacol 2003; 23:S9-S14.
134. Krabbendam L, Myin-Germeys I, Hanssen M, et al. Hallucinatory experiences and onset of psychotic disorder: evidence that the risk is mediated by delusion formation. Acta Psychiatr Scand 2004; 110:264-272.
135. Rice J, Reich T, Andreasen NC, et al. Familial transmission of bipolar illness. Arch Gen Psychiatry 1987; 44:441-447.
136. Maziade M, Roy MA, Rouillard E, et al. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder; a linkage study in 13 target chromosomes. Nature 2001; 6:684-693.
137. 2 dopamine receptor density in psychotic and not nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 1995; 52:471-477.
138. Cohen RM, Semple WE, Gross M, et al. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology 1989; 2:241-254.
139. Bilder RM, Wu H, Bogerts B, et al. Cerebral volume asymmetries in schizophrenia and mood disorders: a quantitative magnetic resonance imaging study. Int J Psychophysiol 1999; 34:197-205.
140. Dasari M, Friedman L, Jesberger J, et al. A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls. Psychiatry Res 1999; 91:155-162.
141. Velakoulis D, Pantelis C, McGorry PD, et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia. Arch Gen Psychiatry 1999; 56:133-140.
142. Rieder RO, Mann LS, Weinberger DR, et al. Computed tomographic scans in patients with schizophrenia, schizoaffective and bipolar disorder. Arch Gen Psychiatry 1983; 40:735-739.
143. Oltmanns TF. Selective attention in schizophrenic and manic psychoses: the effect of distraction on information processing. J Abnorm Psychol 1978; 87:212-225.
144. Rund BR, Orbeck AL, Landro NI. Vigilance deficits in schizophrenics and affectively disturbed patients. Acta Psychiatr Scand 1992; 86:207-212.
145. Sereno AB, Holzman PS. Spatial selective attention in schizophrenic, affective disorder, and normal subjects. Schizophr Res 1996; 20:33-50.
146. Wagemaker H, Lippmann S, Cade JR. Acutely psychotic patients: a treatment approach. South Med J 1985; 78:833-837.
147. Gershon ES, Yuwiler A. Lithium ion: a specific psychopharmacological approach to the treatment of mania. J Neuropsychiatry 1960; 1:229-241.
148. Prien RF, Caffey EM Jr, Klett CJ. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Arch Gen Psychiatry 1972; 27:182-189.
149. Atre-Vaidya N, Taylor MA. Effectiveness of lithium in schizophrenia: do we really have an answer? J Clin Psychiatry 1989; 50:170-173.
150. Lapensee MA. A review of schizoaffective disorder: II. Somatic treatment. Can J Psychiatry 1992; 37:347-349.